Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis

被引:51
作者
Baumgart, Sandra [1 ]
Ellenrieder, Volker [1 ]
Fernandez-Zapico, Martin E. [2 ]
机构
[1] Univ Marburg, Signaling & Transcript Lab, Dept Gastroenterol, Marburg, Germany
[2] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; ENGINEERED MOUSE MODEL; IN-VITRO; INTRAEPITHELIAL NEOPLASIA; DUCTAL ADENOCARCINORNA; MOLECULAR PATHWAYS; SONIC HEDGEHOG; CELL-SURVIVAL; TUMOR-GROWTH; CANCER;
D O I
10.1136/gutjnl-2011-301008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transcription factors are proteins that regulate gene expression by modulating the synthesis of messenger RNA. Since this process is often one dominant control point in the production of many proteins, transcription factors represent the key regulators of numerous cellular functions, including proliferation, differentiation and apoptosis. Pancreatic cancer progression is characterised by activation of inflammatory signalling pathways converging on a limited set of transcription factors that fine-tune gene expression patterns contributing to the growth and maintenance of these tumours. Thus strategies targeting these transcriptional networks activated in pancreatic cancer cells could block the effects of upstream inflammatory responses participating in pancreatic tumorigenesis. The authors review this field of research and summarise current strategies for targeting oncogenic transcription factors and their activating signalling networks in the treatment of pancreatic cancer.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 65 条
  • [1] NF-κB/Rel transcriptional pathway -: Implications in pancreatic cancer
    Algül, H
    Adler, G
    Schmid, RM
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2002, 31 (1-3) : 71 - 78
  • [2] Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
    Arlt, A
    Gehrz, A
    Müerköster, S
    Vorndamm, J
    Kruse, ML
    Fölsch, UR
    Schäfer, H
    [J]. ONCOGENE, 2003, 22 (21) : 3243 - 3251
  • [3] Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer
    Banerjee, S
    Zhang, YX
    Ali, S
    Bhuiyan, M
    Wang, ZW
    Chiao, PJ
    Philip, PA
    Abbruzzese, J
    Sarkar, FH
    [J]. CANCER RESEARCH, 2005, 65 (19) : 9064 - 9072
  • [4] Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)
    Beurel, Eleonore
    Michalek, Suzanne M.
    Jope, Richard S.
    [J]. TRENDS IN IMMUNOLOGY, 2010, 31 (01) : 24 - 31
  • [5] Primers on molecular pathways -: The glycogen synthase kinase-3β
    Billadeau, Daniel D.
    [J]. PANCREATOLOGY, 2007, 7 (5-6) : 398 - 402
  • [6] IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
    Bollrath, Julia
    Greten, Florian R.
    [J]. EMBO REPORTS, 2009, 10 (12) : 1314 - 1319
  • [7] Inflammation and Cancer: IL-6 and STAT3 Complete the Link
    Bromberg, Jacqueline
    Wang, Timothy C.
    [J]. CANCER CELL, 2009, 15 (02) : 79 - 80
  • [8] Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway
    Buchholz, Malte
    Schatz, Alexandra
    Wagner, Martin
    Michl, Patrick
    Linhart, Thomas
    Adler, Guido
    Gress, Thomas M.
    Ellenrieder, Volker
    [J]. EMBO JOURNAL, 2006, 25 (15) : 3714 - 3724
  • [9] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    Burris, HA
    Moore, MJ
    Andersen, J
    Green, MR
    Rothenberg, ML
    Madiano, MR
    Cripps, MC
    Portenoy, RK
    Storniolo, AM
    Tarassoff, P
    Nelson, R
    Dorr, FA
    Stephens, CD
    VanHoff, DD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2403 - 2413
  • [10] Transcription factors as targets for cancer therapy
    Darnell, JE
    [J]. NATURE REVIEWS CANCER, 2002, 2 (10) : 740 - 749